OA09434A - "Thioformamide derivatives". - Google Patents

"Thioformamide derivatives".

Info

Publication number
OA09434A
OA09434A OA59723A OA59723A OA09434A OA 09434 A OA09434 A OA 09434A OA 59723 A OA59723 A OA 59723A OA 59723 A OA59723 A OA 59723A OA 09434 A OA09434 A OA 09434A
Authority
OA
OAPI
Prior art keywords
aryl
alkyl
carbamoyl
represents hydrogen
arylco
Prior art date
Application number
OA59723A
Other languages
English (en)
Inventor
Palfreyman Malcolm Norman
Vicker Nigel
Walsh Roger John Aitchison
Original Assignee
May And Baker Limited Grande B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898900245A external-priority patent/GB8900245D0/en
Priority claimed from GB898900295A external-priority patent/GB8900295D0/en
Application filed by May And Baker Limited Grande B filed Critical May And Baker Limited Grande B
Publication of OA09434A publication Critical patent/OA09434A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Insulating Materials (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Separation, Recovery Or Treatment Of Waste Materials Containing Plastics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Steroid Compounds (AREA)
OA59723A 1989-01-06 1990-01-05 "Thioformamide derivatives". OA09434A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898900245A GB8900245D0 (en) 1989-01-06 1989-01-06 New compositions of matter
GB898900295A GB8900295D0 (en) 1989-01-06 1989-01-06 New compositions of matter

Publications (1)

Publication Number Publication Date
OA09434A true OA09434A (en) 1992-10-15

Family

ID=26294807

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59723A OA09434A (en) 1989-01-06 1990-01-05 "Thioformamide derivatives".

Country Status (16)

Country Link
US (1) US5104883A (fr)
EP (1) EP0377532B1 (fr)
JP (1) JPH02258760A (fr)
KR (1) KR900011727A (fr)
AT (1) ATE78814T1 (fr)
AU (1) AU4761290A (fr)
CA (1) CA2007281A1 (fr)
DE (1) DE69000224T2 (fr)
DK (1) DK0377532T3 (fr)
ES (1) ES2043294T3 (fr)
FI (1) FI900056A7 (fr)
GR (1) GR3005616T3 (fr)
HU (1) HUT53615A (fr)
IL (1) IL92930A0 (fr)
OA (1) OA09434A (fr)
PT (1) PT92796A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000342D0 (en) * 1990-01-08 1990-03-07 May & Baker Ltd New compositions of matter
GB9002879D0 (en) * 1990-02-08 1990-04-04 May & Baker Ltd New compositions of matter
WO1993008168A1 (fr) * 1991-10-14 1993-04-29 Eisai Co., Ltd. Derive de thioformamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100970B1 (fr) * 1970-07-30 1975-08-01 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
GR3005616T3 (fr) 1993-06-07
EP0377532A1 (fr) 1990-07-11
DK0377532T3 (da) 1992-09-14
DE69000224T2 (de) 1993-01-14
ATE78814T1 (de) 1992-08-15
HUT53615A (en) 1990-11-28
PT92796A (pt) 1990-07-31
US5104883A (en) 1992-04-14
ES2043294T3 (es) 1993-12-16
DE69000224D1 (en) 1992-09-03
FI900056A0 (fi) 1990-01-05
KR900011727A (ko) 1990-08-02
JPH02258760A (ja) 1990-10-19
EP0377532B1 (fr) 1992-07-29
AU4761290A (en) 1990-07-12
CA2007281A1 (fr) 1990-07-06
HU900050D0 (en) 1990-03-28
IL92930A0 (en) 1990-09-17
FI900056A7 (fi) 1990-07-07

Similar Documents

Publication Publication Date Title
KR900009660A (ko) 신규 화합물들
EP0976732A4 (fr) Derives amines cycliques 1,4-substitues
EP1035123A4 (fr) Nouveaux composes heterocycliques
FI904602A0 (fi) Pyrazoloderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
ES2091212T3 (es) Compuestos de xantina.
GR3018544T3 (en) Benzamides
ES2168383T3 (es) Derivados de 1,2,3,4-tetrahidroquinoxalindiona y su utilizacion como antagonistas del glutamato receptor.
DK0378518T3 (da) Adenosinderivater med farmaceutisk aktivitet som antihypertensiva
AU579872B2 (en) 2-amino-4-substituted oxazolines
NO895023D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminderivater.
DE69000224D1 (en) Thioformamidderivate.
DK526087D0 (da) Antikonvulsive aminosyrederivater
IL94605A (en) Substituted aminoalkylbenzene derivatives, their manufacture and pharmaceutical compositions containing them
IL141114A0 (en) NOVEL C-2 S/O- AND S/N FORMALDEHYDE ACETAL DERIVATIVES OF CARBAPENEM-3-CARBOXYLIC ACIDS AND THEIR USE AS ANTIBIOTICS AND β-LACTAMASE INHIBITORS
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
AU1619197A (en) Cyclic amic acid derivatives
AU653019B2 (en) New urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
ES2087812A1 (es) Derivados de decahidroisoquinolina utiles como antagonistas de los receptrores de los aminoacidos excitadores.